- Isaac-Mertens Syndrome is a rare neurological condition characterized by muscle stiffness, continuous muscle fiber activity, and fasciculations. Management includes anti-seizure drugs, immunosuppressive agents, and symptomatic therapies aimed at reducing peripheral nerve hyperactivity.
- The market is experiencing demand growth due to increased case identification, enhanced physician knowledge, and ongoing research into autoimmune neurology.
- North America dominates the market owing to established diagnostic infrastructure, research funding, and availability of neurologists.
- Asia-Pacific is expected to witness the fastest CAGR, fueled by medical tourism, improved access to rare disease treatments, and public health investments.
- Anti-seizure medications are expected to hold the largest market share of 41.13% in 2025, driven by their primary role in managing neuromuscular hyperactivity and widespread clinical familiarity.
